Purchase Order 75D30123P17003
Award Date
7/15/23
Potential Completion Date
8/15/23
Potential Value
$75K
Federal Agency
CDC Pittsburgh
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morgantown, WV 26505, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $105,921.20 contract is for sample reagents with a completion date of November 7, 2022. This award was not set aside for any socioeconomic category. Roche Diagnostics has held numerous federal contracts, including...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, for the supply of lab supplies. The potential value of the contract is $119,383.20, and the period of performance runs through April 1, 2019. The contract does not have a set-aside designation. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $108,800.00, is for preventative maintenance services to be performed by March 31, 2028. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the purchase of COBAS PURE C303/E402 clinical chemistry analyzers and associated reagents and supplies. The $460,000.00 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh on April 24, 2023, with an ultimate completion date of December 31, 2023. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned,...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the provision of COBAS assay medical laboratory equipment and supplies. The $68,149.02 firm-fixed-price contract was awarded on April 30, 2024 by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, and has an ultimate completion date of September 30, 2024. This contract is not a set-aside award. Roche Diagnostics, a foreign-owned for-profit manufacturer,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the maintenance of COBAS HIV with Operations capabilities. The award, which has a ceiling value of $572,044.24 and an ultimate completion date of September 4, 2028, does not have a set-aside designation. Roche Diagnostics, a foreign-owned for-profit manufacturer of in vitro diagnostic products, has received...
This is a $86,944 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for a ROCHE SERVICE AGREEMENT with a period of performance through September 2024. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call award from the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, for $242,400.00 in laboratory supplies, linear array genotyping, and detection kits. The award has an ultimate completion date of April 27, 2017. Roche Diagnostics is a for-profit, foreign-owned manufacturer that has received numerous federal contract awards, including from the...